Clinical Significance of Helicopter Transportation for Patients With Acute Illness Admitted to Medical Intensive Care Unit Authors: Shohei Kawakami, Akihiro Shirakabe, Masato Matsushita, Shota Shigihara, Kenichi Tani, Tomofumi Sawatani, Masaki Morooka, Masahito Takahashi, Riku Toguchi, Yuto Yata, Keiichiro Otsubo, Nobuaki Kobayashi, Yoshiaki Hara, Shoji Yokobori, Kuniya Asai Published: 2026 ABSTRACT BackgroundWe aimed to elucidate the characteristics and prognosis of patients admitted to a medical intensive care unit (ICU) by helicopter emergency medical service (HEMS).Methods and ResultsAmong 11,140 patients transported via the institute’s HEMS from January 2012 to December 2021, 459 were admitted to the medical ICU and included as the HEMS group. The 3,810 patients who were transported by other means to the medical ICU comprised the non-HEMS group. Multivariable logistic regression analysis revealed that cardiovascular etiologies other than acute heart failure (AHF), as well as younger age and the requirement of mechanical support (endotracheal intubation and intra-aortic balloon pumping), were associated with HEMS transport. Kaplan–Meier curve analysis revealed that 365-day survival was significantly better in the HEMS group than in the non-HEMS group. A multivariable Cox regression model identified HEMS transport as an independent predictor of a favorable 365-day all-cause survival (hazard ratio: 1.326, 95% confidence interval: 1.024–1.718, P=0.033) relative to other means of transport.ConclusionsCardiovascular diseases other than AHF were the main reasons for helicopter transportation to the medical ICU. The HEMS group were younger and more likely to require circulatory/respiratory assist devices than the non-HEMS group. The HEMS was significantly associated with better 365-day survival; therefore, appropriate transportation means need to be selected to improve the prognosis of non-surgical patients. Central Figure Patients with cardiovascular disease generally require rapid transport to minimize the time to initial therapy. Air ambulances (i.e., helicopters with a critical care doctor and nurse on board) have become common in all Japanese prefectures in recent years. The helicopter emergency medical service (HEMS) was first introduced to Nippon Medical School Chiba Hokusoh Hospital as part of a national project in October 2001.1 In the 25 years since, the life expectancy of the Japanese population has increased to 87 for females and 81 for males in 2020, the highest in the world for both sexes, which explains why patients who require intensive care in Japan are older than they used to be.2 Furthermore, traffic accidents have decreased owing to technological developments. Therefore, the societal need for the HEMS might have changed over time to a larger proportion of non-surgical cases. In the Danish HEMS database, approximately 40% of patients transported via the HEMS from 2014 to 2018 had cardiovascular emergencies.3 Regarding acute medical emergencies, acute coronary syndrome (ACS) is a representative disease for which patients need early access to advanced life support and subsequent rapid transport to a hospital.4 Use of the HEMS has been demonstrated to improve the time-to-treatment of patients with ACS.5–7 Nippon Medical School Chiba Hokusoh Hospital has 2 intensive care units (ICUs; surgical and medical), each with a closed management structure. Patients are admitted to the medical ICU for various reasons, including cardiovascular disease (ACS, acute heart failure [AHF], and arrythmias such as ventricular tachycardia and/or ventricular fibrillation) and noncardiovascular disease (acute exacerbation of chronic obstructive pulmonary disease [COPD], hypoxia due to pneumonia, hemorrhagic shock, and septic shock). The severity of illness and long-term prognostic impact among patients transported by the HEMS has not been investigated in non-surgical patients who require intensive care. Therefore, the aim of this study was to clarify the associations between HEMS transport and patient characteristics, management, and long-term prognoses. The findings may assist critical care doctors and nurses to decide, during an emergency call, whether a patient with an acute condition should be transported via the HEMS. Methods HEMS Dispatch The HEMS of Nippon Medical School Chiba Hokusoh Hospital serves patients with emergencies within a 50 km radius (15 min), including the north of Chiba Prefecture and the south of Ibaraki Prefecture.8 It is available from sunrise to 30 min before sunset, and many patients have been transported in this way, including those with multiple trauma, burns, shock, and cardiovascular, cerebrovascular, or respiratory distress. The HEMS request criteria are as follows: (1) definite or suspected, imminent life-threating situation; (2) predicted prolonged transfer to hospital via ground ambulance due to congestion on the roads; (3) necessity to shorten transfer owing to condition (e.g., severe burns, multiple trauma, or limb amputation); and 4) requirement of an on-site emergency operation by the doctor. The doctor makes a decision regarding the dispatch strategies on-site as follows: (1) transfer the patient via normal ambulance to a nearby medical institute without an accompanying doctor; (2) transfer the patient via the HEMS to a nearby medical institute with an accompanying doctor; or (3) transfer the patient via the HEMS to Nippon Medical School Chiba Hokusoh Hospital with an accompanying doctor. During the study period, 11,140 patients were transported via the HEMS (5,392 to Nippon Medical School Chiba Hokusoh Hospital). Patients We screened 4,474 patients admitted to the medical ICU from the emergency room and general wards of Nippon Medical School Chiba Hokusoh Hospital in Inzai, Japan, between January 2012 and December 2021. Among them, 198 patients who were re-admitted to the medical ICU during the same hospitalization period and 7 for whom the hospitalization route was unknown were excluded from this retrospective study. Ultimately, 4,269 patients were included as the study group. The medical ICU at Nippon Medical School Chiba Hokusoh Hospital functions as a cardiac and non-cardiac care unit, and all the physicians on staff are cardiologists. An average of 8–10 cardiologists have been employed in this unit at a given time during the past decade, including 3–4 double board-certified intensivists. Approximately 60–70% of the included patients had cardiovascular diseases. Patients who were admitted to the medical ICU but underwent a subsequent cardiovascular surgical procedure (e.g., surgery for blow-out or an oozing rupture and ventricular septum perforation after acute myocardial infarction, surgery for worsening acute aortic disease, or thrombectomy for pulmonary embolism) were included in this study. Major diseases (e.g., ACS, AHF, and sepsis) were diagnosed based on the latest guidelines as of 2024.9–11 Heart failure (HF) was diagnosed by the treating physician at the emergency room according to the European Society of Cardiology (ESC) and Japanese guidelines for the diagnosis of HF.12–14 It was comprehensively diagnosed based on clinical history (symptoms, functional limitation, prior cardiac disease, risk factors, exacerbating factors, comorbidities, and drug use), the results of a physical examination, and the results of initial investigations (chest radiography; 12-lead ECG; concentrations of troponins, blood urea nitrogen, creatinine, sodium, potassium, and glucose; liver function; and complete blood count). Plasma natriuretic peptide levels were measured, and echocardiography was performed to supplement the evidence for the diagnosis of HF. AHF was defined as a gradual or rapid change in the signs and symptoms of HF that resulted in the need for urgent therapy. The treating physician in the emergency department diagnosed AHF within 30 min of admission, based on the results of these procedures. All included patients had a New York Heart Association functional class of either III or IV. Diuretics or vasodilators were administered for AHF to all included patients. Patients with any of the following 3 needs required intensive care: (1) high-flow oxygen therapy (including mechanical support) for orthopnea; (2) inotropes or mechanical support because for low blood pressure; or (3) intravenous diuretics for generalized or lung edema. Patients with the following conditions were admitted to the medical ICU in the present study: ACS, AHF, other cardiovascular diseases (arrhythmia, acute aortic dissection, pulmonary embolism, coronary spasm angina, takotsubo cardiomyopathy, or pericarditis), sepsis (severe sepsis, septic shock, infective endocarditis, pneumonia, or myocarditis), and other noncardiovascular diseases (emergency neurological, gastroenterological, hematological, or endocrinological diseases; emergency respiratory diseases [interstitial pneumonia, acute exacerbation of COPD, or status asthmaticus]; acute kidney injury; or severe symptoms that required a differential diagnosis). Although the ICU does not have definitive criteria for admission, these conditions occurred throughout the study period. Procedure Patients requiring intensive care were categorized into 2 groups according to their means of transportation to the emergency room: the HEMS group (n=459) and the non-HEMS group (n=3,810). The groups were compared in terms of age, sex, etiology, medical history (diabetes mellitus, hypertension, dyslipidemia, and hyperuricemia), vital signs and status upon admission (systolic blood pressure, diastolic blood pressure, heart rate, respiratory rate, body temperature, body mass index, and left ventricular ejection fraction [LVEF]), arterial blood gas parameters (pH, CO2 partial pressure, O2 partial pressure, HCO3−, O2 saturation, and the lactate concentration), laboratory data (white blood cell count, hemoglobin level, and concentrations of blood urea nitrogen, creatinine, sodium, potassium, blood glucose, C-reactive protein, and B-type natriuretic peptide), and mechanical support during the ICU stay (noninvasive positive pressure ventilation, endotracheal intubation, intra-aortic balloon pumping, percutaneous cardiopulmonary support, and continuous hemodiafiltration). Acute Physiology and Chronic Health Evaluation (APACHE II) scores15 were also compared between groups. LVEF was calculated at admission via the Teichholz method or Simpson’s method using a Sonos 5500 (Hewlett Packard, Palo Alto, CA, USA) or Vivid i (GE Yokogawa Medical, Tokyo, Japan) ultrasound system. The method was chosen on a case-by-case basis. Because LVEF was measured during the acute phase, it was not adequately evaluated in patients with severe orthopnea. We identified factors that were significantly associated with HEMS transfer by performing a multivariable logistic regression analysis. Prognostic Evaluation According to Year of Admission The primary endpoint of this study was the long-term prognosis, including 365-day all-cause death. We evaluated the prognostic impact of HEMS transfer on 365-day death relative to non-HEMS transfer by using a Cox proportional-hazards regression model and Kaplan‒Meier curves. All-cause death was ascertained using information obtained directly from hospital medical records or from other institutes via telephone. Statistical Analysis All statistical analyses were performed using IBM SPSS Statistics version 22.0 (IBM Corp., USA). All numerical data are expressed as the median (25–75th percentiles) because they were non-normally distributed. Normality was assessed using the Shapiro‒Wilk test. The Mann–Whitney U test was used for comparisons between groups. The chi-squared test was used to compare proportions. P values <0.05 were considered statistically significant. A multivariable logistic regression analysis was performed to determine the odds ratios (ORs) for the factors associated with helicopter transfer. In model 1, we included clinical diagnoses (ACS, AHF, acute aortic disease, pulmonary thrombo-embolism, arrhythmia, coronary spasms, takotsubo cardiomyopathy and sepsis) and APACHE II score (per 1-point increase). In model 2, all clinically relevant factors that might affect HEMS transfer (age [per 1-year increase], sex [male], systolic blood pressure [per 10 mmHg decrease], endotracheal intubation [yes], intra-aortic balloon pumping [yes], percutaneous cardiopulmonary support [yes], and noninvasive positive pressure ventilation [yes]) and APACHE II score (per 1-point increase) were included via simultaneous forced entry. The cumulative survival rates of each group were analyzed using Kaplan‒Meier curves, and the log-rank test was used to determine whether differences were statistically significant. A multivariable Cox regression analysis was performed to compare the risk for all-cause death between groups, with non-HEMS transfer as the reference group. Sex (male), age (per 1-year increase), hemoglobin level (per 1.0 g/dL decrease), sepsis (yes), AHF (yes), estimated glomerular filtration rate (per 0.1 mL/min/1.73 m2 increase), B-type natriuretic peptide (per 10 pg/mL increase), APACHE II score (per 1-point increase), continuous hemodiafiltration (yes), and percutaneous cardiopulmonary support (yes) were selected for inclusion in this model. Ethical Review The Research Ethics Committee of Nippon Medical School Chiba Hokusoh Hospital approved the study protocol. Owing to its retrospective design, the need for written informed consent was waived. Based on the Ethics Committee’s advice, the present study was presented as a poster in the hospital and published on the hospital’s homepage, where it could be viewed by anyone. All procedures were performed in accordance with the tenets of the Declaration of Helsinki. Results Characteristics of the HEMS Group Details of HEMS transfers during the study period are illustrated in Figure 1. Among the 11,140 patients transported by HEMS during the study period, 459 (4.1%) were admitted to the medical ICU for acute illness and compared with 3,810 patients admitted to the same ICU for acute illness via non-HEMS routes (Figure 2), together forming the study cohort (N=4,269). Figure 1.Number of patients requiring HEMS and reasons for transport to hospital. In total, 11,140 patients required the HEMS, of whom 5,392 were transported to Nippon Medical School Chiba Hokusoh Hospital, including 1,659 with acute illness. Of these, 459 patients were treated in the medical ICU. HEMS, helicopter emergency medical service; ICU, intensive care unit. Figure 2.Patient selection process. ACS, acute coronary syndrome; AHF, acute heart failure; HEMS, helicopter emergency medical service Number of patients requiring HEMS and reasons for transport to hospital. In total, 11,140 patients required the HEMS, of whom 5,392 were transported to Nippon Medical School Chiba Hokusoh Hospital, including 1,659 with acute illness. Of these, 459 patients were treated in the medical ICU. HEMS, helicopter emergency medical service; ICU, intensive care unit. Patient selection process. ACS, acute coronary syndrome; AHF, acute heart failure; HEMS, helicopter emergency medical service The patients’ characteristics are summarized in Table 1. They comprised 3,047 men (71.4%) and 1,222 women (28.6%), with a median age of 71 [61–79] years. Patients in the HEMS group were significantly younger than those in the non-HEMS group. In the study cohort, 1,833 (42.9%), 975 (22.8%), and 761 (17.8%) patients had ACS, AHF, and other cardiovascular diseases, respectively. In addition, 321 (7.5%) and 379 (8.9%) patients developed sepsis and other noncardiovascular diseases, respectively. Significantly larger proportions of patients with ACS and arrhythmia were transported by the HEMS than by other means, while significantly smaller proportions of those with AHF, sepsis, and other noncardiovascular diseases were transported by the HEMS. Table 1.Associations Between Patient Characteristics and HEMSCharacteristicAll (N=4,269)Hospitalization routeP valueNon-HEMS (n=3,810)HEMS (n=459)Age (years)71 (61–79)71 (62–79)67 (59–76)<0.001Sex (male, %)3,047 (71.4%)2,699 (70.8%)348 (75.8%)0.025Diagnosis Acute coronary syndrome (n, %)1,833 (42.9%)1,571 (41.2%)262 (57.1%)<0.001 Acute heart failure (n, %)975 (22.8%)924 (24.3%)51 (11.1%)<0.001 Acute aortic disease (n, %)182 (4.3%)155 (4.1%)27 (5.9%)0.085 Pulmonary thrombo-embolism (n, %)142 (3.3%)128 (3.4%)14 (3.1%)0.890 Arrhythmia (n, %)318 (7.5%)264 (6.9%)54 (11.7%)<0.001 Coronary spasms (n, %)50 (1.2%)45 (1.2%)5 (1.1%)>0.999 Takotsubo cardiomyopathy (n, %)69 (1.6%)62 (1.6%)7 (1.5%)>0.999 Sepsis (n, %)321 (7.5%)299 (7.8%)22 (4.8%)0.019 Other noncardiovascular disease (n, %)379 (8.9%)362 (9.5%)17 (3.7%)<0.001Medical history Hypertension (n, %)2,960 (69.3%)2,661 (69.8%)299 (65.1%)0.042 Diabetes mellitus (n, %)1,619 (37.9%)1,458 (38.3%)161 (35.1%)0.186 Dyslipidemia (n, %)2,183 (51.1%)1,940 (50.9%)243 (52.9%)0.429 Hyperuricemia (n, %)1,223 (28.6%)1,082 (28.4%)141 (30.7%)0.300 Hemodialysis before admission (n, %)253 (5.9%)243 (6.4%)10 (2.2%)<0.001 CKD (n, %)1,216 (28.5%)1,121 (29.4%)95 (20.7%)<0.001Vital signs and status Systolic blood pressure (mmHg)139 (110–163)140 (112–164)131 (103–158)<0.001 Diastolic blood pressure (mmHg)79 (60–94)79 (60–95)80 (59–91)0.362 Pulse (beats/min)87 (70–107)88 (70–108)80 (61–100)<0.001 Respiratory rate (breaths/min)20 (16–27)20 (16–27)20 (16–26)0.137 Body temperature (℃)36.4 (35.9–36.8)36.4 (35.9–36.9)36.1 (35.5–36.5)<0.001 Body mass index (kg/m2)23.4 (21.0–26.1)23.4 (20.9–26.0)24.1 (21.8–26.8)0.004 LVEF (%)51 (39–63)51 (38–63)52 (40–61)0.381Arterial blood gas parameters pH7.41 (7.34–7.44)7.41 (7.34–7.45)7.40 (7.32–7.44)0.324 Partial pressure of CO2 (mmHg)37 (32–42)37 (32–42)37 (31–43)0.370 Partial pressure of O2 (mmHg)112 (82–164)108 (80–154)165 (113–227)<0.001 HCO3– (mmol/L)22.7 (19.5–25.1)23.8 (19.7–25.1)22.0 (18.5–24.4)<0.001 O2 saturation (%)98 (96–99)98 (96–99)99 (98–99)<0.001 Lactate (mmol/L)1.6 (1.1–2.9)1.6 (1.0–2.8)2.2 (1.4–4.0)<0.001Laboratory data WBCs (/L)9,310 (7,100–12,200)9,300 (7,100–12,158)9,500 (7,425–12,200)0.239 Hemoglobin (g/dL)13.1 (11.0–14.7)13.0 (10.9–14.6)13.8 (12.3–15.1)<0.001 BUN (mg/dL)19.2 (14.8–31.0)19.6 (14.7–32.0)18.0 (14.5–23.3)<0.001 Creatinine (mg/dL)0.97 (0.74–1.52)0.98 (0.75–1.31)0.93 (0.73–1.13)0.036 Sodium (mmol/L)140 (137–142)140 (137–142)140 (138–142)0.035 Potassium (mmol/L)4.1 (3.8–4.5)4.1 (3.8–4.5)4.1 (3.8–4.5)0.013 BG (mg/dL)151 (120–228)149 (118–214)177 (139–254)<0.001 CRP (mg/dL)0.42 (0.10–2.86)0.49 (0.11–3.16)0.15 (0.06–0.555)<0.001 BNP (pg/mL)172 (41–617)193 (49–660)56 (19–281)<0.001Scoring APACHE II (points)11 (8–17)11 (8–17)11 (8–18)0.962Mechanical support (cases) during ICU stay NPPV (n, %)988 (23.1%)928 (24.4%)60 (13.1%)<0.001 ETI (n, %)830 (19.4%)706 (18.5%)124 (27.0%)<0.001 Pacing (n, %)225 (5.3%)180 (4.7%)45 (5.1%)<0.001 IABP (n, %)593 (13.8%)501 (13.1%)92 (20.0%)<0.001 PCPS (n, %)218 (5.1%)178 (4.7%)40 (8.7%)<0.001 CHDF (n, %)662 (15.2%)602 (15.8%)60 (13.1%)0.133Short-term prognosis ICU hospitalization (days)3 (2–6)3 (2–6)3 (2–6)0.514 Total hospitalization (days)17 (11–30)17 (11–31)16 (11–29)0.962 In-hospital deaths (n, %)561 (13.1%)506 (13.3%)55 (12.0%)0.465P values determined using the Mann–Whitney U test or chi-squared test. Unless otherwise indicated, data are presented as 25–75th percentiles alongside the median. APACHE, Acute Physiology and Chronic Health Evaluation; BNP, B-type natriuretic peptide; CHDF, continuous hemodiafiltration; ETI, endotracheal intubation; IABP, intra-aortic balloon pump; ICU, intensive care unit; PCPS, percutaneous cardiopulmonary support; NPPV, noninvasive positive pressure ventilation. Table 1.Associations Between Patient Characteristics and HEMSCharacteristicAll (N=4,269)Hospitalization routeP valueNon-HEMS (n=3,810)HEMS (n=459)Age (years)71 (61–79)71 (62–79)67 (59–76)<0.001Sex (male, %)3,047 (71.4%)2,699 (70.8%)348 (75.8%)0.025Diagnosis Acute coronary syndrome (n, %)1,833 (42.9%)1,571 (41.2%)262 (57.1%)<0.001 Acute heart failure (n, %)975 (22.8%)924 (24.3%)51 (11.1%)<0.001 Acute aortic disease (n, %)182 (4.3%)155 (4.1%)27 (5.9%)0.085 Pulmonary thrombo-embolism (n, %)142 (3.3%)128 (3.4%)14 (3.1%)0.890 Arrhythmia (n, %)318 (7.5%)264 (6.9%)54 (11.7%)<0.001 Coronary spasms (n, %)50 (1.2%)45 (1.2%)5 (1.1%)>0.999 Takotsubo cardiomyopathy (n, %)69 (1.6%)62 (1.6%)7 (1.5%)>0.999 Sepsis (n, %)321 (7.5%)299 (7.8%)22 (4.8%)0.019 Other noncardiovascular disease (n, %)379 (8.9%)362 (9.5%)17 (3.7%)<0.001Medical history Hypertension (n, %)2,960 (69.3%)2,661 (69.8%)299 (65.1%)0.042 Diabetes mellitus (n, %)1,619 (37.9%)1,458 (38.3%)161 (35.1%)0.186 Dyslipidemia (n, %)2,183 (51.1%)1,940 (50.9%)243 (52.9%)0.429 Hyperuricemia (n, %)1,223 (28.6%)1,082 (28.4%)141 (30.7%)0.300 Hemodialysis before admission (n, %)253 (5.9%)243 (6.4%)10 (2.2%)<0.001 CKD (n, %)1,216 (28.5%)1,121 (29.4%)95 (20.7%)<0.001Vital signs and status Systolic blood pressure (mmHg)139 (110–163)140 (112–164)131 (103–158)<0.001 Diastolic blood pressure (mmHg)79 (60–94)79 (60–95)80 (59–91)0.362 Pulse (beats/min)87 (70–107)88 (70–108)80 (61–100)<0.001 Respiratory rate (breaths/min)20 (16–27)20 (16–27)20 (16–26)0.137 Body temperature (℃)36.4 (35.9–36.8)36.4 (35.9–36.9)36.1 (35.5–36.5)<0.001 Body mass index (kg/m2)23.4 (21.0–26.1)23.4 (20.9–26.0)24.1 (21.8–26.8)0.004 LVEF (%)51 (39–63)51 (38–63)52 (40–61)0.381Arterial blood gas parameters pH7.41 (7.34–7.44)7.41 (7.34–7.45)7.40 (7.32–7.44)0.324 Partial pressure of CO2 (mmHg)37 (32–42)37 (32–42)37 (31–43)0.370 Partial pressure of O2 (mmHg)112 (82–164)108 (80–154)165 (113–227)<0.001 HCO3– (mmol/L)22.7 (19.5–25.1)23.8 (19.7–25.1)22.0 (18.5–24.4)<0.001 O2 saturation (%)98 (96–99)98 (96–99)99 (98–99)<0.001 Lactate (mmol/L)1.6 (1.1–2.9)1.6 (1.0–2.8)2.2 (1.4–4.0)<0.001Laboratory data WBCs (/L)9,310 (7,100–12,200)9,300 (7,100–12,158)9,500 (7,425–12,200)0.239 Hemoglobin (g/dL)13.1 (11.0–14.7)13.0 (10.9–14.6)13.8 (12.3–15.1)<0.001 BUN (mg/dL)19.2 (14.8–31.0)19.6 (14.7–32.0)18.0 (14.5–23.3)<0.001 Creatinine (mg/dL)0.97 (0.74–1.52)0.98 (0.75–1.31)0.93 (0.73–1.13)0.036 Sodium (mmol/L)140 (137–142)140 (137–142)140 (138–142)0.035 Potassium (mmol/L)4.1 (3.8–4.5)4.1 (3.8–4.5)4.1 (3.8–4.5)0.013 BG (mg/dL)151 (120–228)149 (118–214)177 (139–254)<0.001 CRP (mg/dL)0.42 (0.10–2.86)0.49 (0.11–3.16)0.15 (0.06–0.555)<0.001 BNP (pg/mL)172 (41–617)193 (49–660)56 (19–281)<0.001Scoring APACHE II (points)11 (8–17)11 (8–17)11 (8–18)0.962Mechanical support (cases) during ICU stay NPPV (n, %)988 (23.1%)928 (24.4%)60 (13.1%)<0.001 ETI (n, %)830 (19.4%)706 (18.5%)124 (27.0%)<0.001 Pacing (n, %)225 (5.3%)180 (4.7%)45 (5.1%)<0.001 IABP (n, %)593 (13.8%)501 (13.1%)92 (20.0%)<0.001 PCPS (n, %)218 (5.1%)178 (4.7%)40 (8.7%)<0.001 CHDF (n, %)662 (15.2%)602 (15.8%)60 (13.1%)0.133Short-term prognosis ICU hospitalization (days)3 (2–6)3 (2–6)3 (2–6)0.514 Total hospitalization (days)17 (11–30)17 (11–31)16 (11–29)0.962 In-hospital deaths (n, %)561 (13.1%)506 (13.3%)55 (12.0%)0.465P values determined using the Mann–Whitney U test or chi-squared test. Unless otherwise indicated, data are presented as 25–75th percentiles alongside the median. APACHE, Acute Physiology and Chronic Health Evaluation; BNP, B-type natriuretic peptide; CHDF, continuous hemodiafiltration; ETI, endotracheal intubation; IABP, intra-aortic balloon pump; ICU, intensive care unit; PCPS, percutaneous cardiopulmonary support; NPPV, noninvasive positive pressure ventilation. Associations Between Patient Characteristics and HEMS P values determined using the Mann–Whitney U test or chi-squared test. Unless otherwise indicated, data are presented as 25–75th percentiles alongside the median. APACHE, Acute Physiology and Chronic Health Evaluation; BNP, B-type natriuretic peptide; CHDF, continuous hemodiafiltration; ETI, endotracheal intubation; IABP, intra-aortic balloon pump; ICU, intensive care unit; PCPS, percutaneous cardiopulmonary support; NPPV, noninvasive positive pressure ventilation. Compared with patients transported by other means, those transported by the HEMS had significantly lower systolic blood pressure. The prevalence of underlying comorbidities, including chronic kidney disease, was lower in the HEMS group than in the non-HEMS group. In terms of laboratory findings, patients in the HEMS group had significantly higher hemoglobin values and lower serum levels of blood urea nitrogen, creatinine, potassium, C-reactive protein, and B-type natriuretic peptide than those in the non-HEMS group. Moreover, the use of some means of additional mechanical support (endotracheal intubation, temporary pacing, intra-aortic balloon pumping, and percutaneous cardiopulmonary support) was significantly more common in the HEMS group. APACHE II scores did not significantly differ between the groups (11 [8–17] and 11 [11–18] for the non-HEMS and HEMS groups, respectively). The median ICU stay also did not differ between them. These results suggested that younger patients with pure cardiovascular disease and no comorbidities who developed an unstable circulatory and/or respiratory condition were the most common group to be transported to the medical ICU via the HEMS. Multivariable logistic regression analysis identified several factors that were independently associated with HEMS transport (Table 2). Regarding the diagnosis, the following cardiovascular diseases (all except for AHF) were independently associated with HEMS transport: ACS (OR: 4.077, 95% confidence interval [CI]: 2.450–6.786, P<0.001), acute aortic disease (OR: 4.126, 95% CI: 2.178–7.815, P<0.001), pulmonary thrombo-embolism (OR: 2.571, 95% CI: 1.229–5.380, P=0.012), arrhythmia (OR: 4.069, 95% CI: 2.301–7.194, P<0.001), coronary spasms (OR: 2.867, 95% CI: 1.003–8.194, P=0.049) and takotsubo cardiomyopathy (OR: 2.631, 95% CI: 1.045–6.621, P=0.040). Regarding the characteristics of the patients, being younger (per 1-year decrease) and requiring mechanical support (endotracheal intubation and intra-aortic balloon pumping) were independently associated with HEMS transport. Table 2.Multivariable Logistic Regression Model for Associations With HEMS Transport Model 1Model 2OR95% CIP valueOR95% CIP valueDiagnosis Acute coronary syndrome (yes)4.0772.450–6.786<0.001 Acute heart failure (yes)1.1980.683–2.1040.528 Acute aortic disease (yes)4.1262.178–7.815<0.001 Pulmonary thrombo-embolism (yes)2.5711.229–5.3800.012 Arrhythmia (yes)4.0692.301–7.194<0.001 Coronary spasms (yes)2.8671.003–8.1940.049 Takotsubo cardiomyopathy (yes)2.6311.045–6.6210.040 Sepsis (yes)1.5130.788–2.9050.213 Characteristics Age (per 1-year decrease) 1.0141.007–1.022<0.001 Sex (male) 1.2110.964–1.5210.099 ETI (yes) 1.4191.065–1.8910.017 IABP (yes) 1.3931.066–1.8190.015 APACHE II score (per 1-point increase)1.0231.011–1.035<0.0011.0020.988–1.0170.746CI, confidence interval; HEMS, helicopter emergency medical service; OR, odds ratio. Other abbreviations as in Table 1. Table 2.Multivariable Logistic Regression Model for Associations With HEMS Transport Model 1Model 2OR95% CIP valueOR95% CIP valueDiagnosis Acute coronary syndrome (yes)4.0772.450–6.786<0.001 Acute heart failure (yes)1.1980.683–2.1040.528 Acute aortic disease (yes)4.1262.178–7.815<0.001 Pulmonary thrombo-embolism (yes)2.5711.229–5.3800.012 Arrhythmia (yes)4.0692.301–7.194<0.001 Coronary spasms (yes)2.8671.003–8.1940.049 Takotsubo cardiomyopathy (yes)2.6311.045–6.6210.040 Sepsis (yes)1.5130.788–2.9050.213 Characteristics Age (per 1-year decrease) 1.0141.007–1.022<0.001 Sex (male) 1.2110.964–1.5210.099 ETI (yes) 1.4191.065–1.8910.017 IABP (yes) 1.3931.066–1.8190.015 APACHE II score (per 1-point increase)1.0231.011–1.035<0.0011.0020.988–1.0170.746CI, confidence interval; HEMS, helicopter emergency medical service; OR, odds ratio. Other abbreviations as in Table 1. Multivariable Logistic Regression Model for Associations With HEMS Transport CI, confidence interval; HEMS, helicopter emergency medical service; OR, odds ratio. Other abbreviations as in Table 1. Prognostic Differences According to Transport Means The median follow-up period was 365 (162–365) days. Among the 4,269 patients, 561 (13.1%) died in hospital and 818 (19.2%) died within 365 days. The in-hospital mortality rate did not significantly differ between the HEMS and non-HEMS groups (12.0% vs. 13.3%). The Kaplan‒Meier curves for the different types of transport are shown in Figure 3. The survival rate in the HEMS group was significantly higher than that in the non-HEMS group. The multivariable Cox regression model identified HEMS transport as independently associated with a favorable 365-day all-cause survival (HR: 1.326, 95% CI: 1.024–1.718, P≤0.033) relative to non-HEMS transport. Figure 3.Kaplan–Meier survival curves and Cox regression model for the HEMS and non-HEMS groups. The Kaplan–Meier survival curves revealed that the prognosis (all-cause death within 365 days) was significantly poorer in the non-HEMS group than in the HEMS group. The Cox regression model indicated that HEMS transport was an independent predictor of 365-day survival (HR: 1.326, 95% CI: 1.024–1.718, P=0.033). Adjusting factors: age (per 1-year increase), sex (male), Acute Physiology and Chronic Health Evaluation II score (per 1.0-point increase), percutaneous cardiopulmonary support (yes), continuous hemodiafiltration (yes), sepsis (yes), acute heart failure (yes), hemoglobin level (per 1.0 g/dL decrease), estimated glomerular filtration rate (per 0.1 mL/min/1.73 m2 increase), and brain natriuretic peptide concentration (per 10 pg/mL increase). CI, confidence interval; HEMS, helicopter emergency medical service; HR, hazard ratio. Kaplan–Meier survival curves and Cox regression model for the HEMS and non-HEMS groups. The Kaplan–Meier survival curves revealed that the prognosis (all-cause death within 365 days) was significantly poorer in the non-HEMS group than in the HEMS group. The Cox regression model indicated that HEMS transport was an independent predictor of 365-day survival (HR: 1.326, 95% CI: 1.024–1.718, P=0.033). Adjusting factors: age (per 1-year increase), sex (male), Acute Physiology and Chronic Health Evaluation II score (per 1.0-point increase), percutaneous cardiopulmonary support (yes), continuous hemodiafiltration (yes), sepsis (yes), acute heart failure (yes), hemoglobin level (per 1.0 g/dL decrease), estimated glomerular filtration rate (per 0.1 mL/min/1.73 m2 increase), and brain natriuretic peptide concentration (per 10 pg/mL increase). CI, confidence interval; HEMS, helicopter emergency medical service; HR, hazard ratio. Discussion More than 10,000 patients were transported by the HEMS of Nippon Medical School Chiba Hokusoh Hospital in Japan between January 2012 and December 2021. Among the 5,392 patients who were transported via the HEMS, approximately 30% (1,659 patients) had acute illnesses, of whom 459 (27.7%) required treatment in the medical ICU. Patients admitted to the medical ICU via the HEMS were mainly young, had pure cardiovascular diseases without comorbidities, and had suddenly developed an unstable circulatory and/or respiratory condition compared with those admitted via other routes. Transport via the HEMS was associated with better outcomes over the next 365 days among non-surgical patients who required intensive care than those using other means of transport. Thus, the HEMS may yield a better long-term prognosis for such patients. HEMS for Medical Diseases The HEMS is one of the fastest and most efficient ways to transport patients with medical emergencies. The HEMS project was started in 2001 by the Japanese Government and medical professionals based on the dire consequences of the Great Hanshin-Awaji Earthquake in 1995. That catastrophic disaster exposed the inadequacies of Japan’s aerial medical system.16 As it was widely used during natural disasters and for road traffic accidents and other emergencies at its inception, initially the most common condition of HEMS-transported patients was trauma.17,18 Prehospital healthcare and emergency medical services vary greatly among countries, especially among Western countries,19–21 and since the inception of the HEMS in 2001, Japanese society and prehospital emergency care have undergone major changes. In 1966, 42% of patients transported by ambulance needed treatment for trauma, but by 2003, only 26.4% needed such treatment, while 58.4% had critical illnesses. In 1986, when the Firefighting Organization Acts were revised for the third time, emergency care for acute critical illness was specifically delineated as a major purpose of the emergency medical service.22 From January 2008 to January 2012, approximately 20–30% of patients with acute illnesses were transported by the HEMS in Japan,23 consistent with the results of the present study. Japanese society is now facing social issues associated with its population’s high life expectancy, including a rapid increase in the prevalence of acute illness. Accordingly, although patients transported by the HEMS in the present study were younger than those transported by other means, our strategy may need to shift to accommodate a larger proportion of aged patients with acute illness via the HEMS over the next decade. Cardiovascular disease, in particular ACS, is one of the most critical diseases among patients with acute illness.24 The importance of the clinical availability of the HEMS to shorten the “door-to-balloon time” was described in the guidelines for ACS by the Japanese Circulation Society.11 Many studies on this issue have already been published, including our report that patients with severe ACS who require early reperfusion are most appropriately triaged and more rapidly transferred via the HEMS; the lower mortality rate in the HEMS group after propensity score matching suggested that the HEMS may reduce cardiac deaths in patients with ACS.4,5 The HEMS has also been recommended for consideration in cases of life-threatening arrythmia and cardiac arrest.25 The European Resuscitation Council Guidelines for cardiac arrest in special circumstances mentions the most important measures to prevent the need for in-flight cardiopulmonary resuscitation during HEMS missions.26 These include proper pre-flight evaluation of the patient, early recognition and communication within the team, early defibrillation, high-quality cardiopulmonary resuscitation with minimal interruption of chest compressions, and treatment of reversible causes before the return flight commences. Ali et al. suggest that initiation of extracorporeal cardiopulmonary resuscitation by the HEMS team reduces the low-flow time and improves outcomes in patients with refractory out-of-hospital cardiac arrest.27 A patient with arrhythmia, pulmonary embolism, and acute aortic disease is at high risk of out-of-hospital cardiac arrest. Therefore, determining whether the HEMS is a suitable method of transport before their circulation ceases may be important. Almost all patients with AHF in the present cohort suffered from orthopnea; considering that patients transported via the HEMS have to lie down, such patients may not be suited for this means of transport. The prognosis of patients transported via the HEMS may be optimized via an appropriate patient-selection strategy by the on-site emergency team. Impact of ICU Management Structure on Prognosis of In-Hospital Emergency Larger proportions of patients transported by the HEMS in our study required mechanical support in the form of endotracheal intubation, temporary pacing, intra-aortic balloon pumping, and percutaneous cardiopulmonary support than those transported by other means. Among these, mechanical ventilation via endotracheal intubation and intra-aortic balloon pumping were independently associated with HEMS transport. These results suggested that patients in a critical condition (those with an unstable circulatory and respiratory condition) were preferentially transported by the HEMS in our study and that continuous intensive care via mechanical support was essential to improve their prognosis. The Kaplan‒Meier curves intersected during the acute phase between the HEMS and non-HEMS groups, indicating that HEMS transport did not improve survival during this phase due to severity of the HEMS patients. Therefore, uninterrupted meticulous intensive care and post-intensive care are likely needed to improve the long-term prognosis of patients of the HEMS group who are in a critical condition. ICU management structures are generally categorized as “closed” or “open”. In closed ICUs, intensivists oversee the care of all patients, which ensures consistency and specialized management. Multiple studies have demonstrated that closed ICUs are associated with lower ICU/in-hospital mortality rates and shorter ICU stays than open ICUs.28–30 Open ICUs, in which primary physicians remain responsible for patient care, facilitate smoother coordination with wards and quicker transfer decisions but may suffer from inconsistent treatment policies and the diffusion of responsibility.28 Nippon Medical School Chiba Hokusoh Hospital plays a core role in the HEMS system in Chiba Prefecture,8 and also serves as a regional core hospital. We therefore operate a closed medical ICU, which is managed 24 h/day by cardiovascular intensivists.31 These clinicians do not fly to the scene of emergency but work as full-time doctors in the medical ICU. Because our closed ICU system ensures consistency in care, the relatively low mortality rates observed among patients transported via the HEMS might have resulted from the rapid recognition of patient deterioration and on-site initiation of transport decisions. Thus, the combination of early access to advanced life support/subsequent rapid patient transport and careful intensive care by full-time doctors likely yields the best long-term prognosis for patients transported via the HEMS. Study Limitations First, it was a retrospective study performed at a single hospital. Unmeasured variables or missing data may have affected the results, and the definitions of diagnosis and risk and the interpretation of risk factors may have changed between the 2010s and the 2020s. Furthermore, the difficulty in standardizing patient care may have influenced the major findings of this study. Second, we did not have access to detailed data for the period after ICU discharge. Ideally, these data should be included in multivariable analyses of long-term prognosis. Third, the institute does not have definitive criteria for patient selection for HEMS transport and the decision is made on a case-by-case basis by the on-site physician, which might have biased the present study results. Fourth, no prognostic difference was observed between the non-HEMS and HEMS groups for each condition. Lower proportions of patients in the HEMS group had AHF and sepsis, both of which are strong prognostic determinants. These baseline differences alone may explain the observed survival advantage of the HEMS in the overall cohort. Finally, the diagnostic criteria for sepsis changed substantially in 2021. In this study, sepsis was diagnosed using the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.7 Consequently, some patients with sepsis under these criteria were not diagnosed with sepsis at the time of admission during 2012–2020. Conclusions Medical ICU admissions accounted for 4.1% of all patients transported by the institute’s HEMS during the study period. Cardiovascular diseases other than AHF were the main reason for transport via the HEMS. These patients were also younger, on average, and more likely to require circulatory/respiratory assist devices than those admitted via other routes. The HEMS was significantly associated with better 365-day survival; therefore, appropriate transportation means need to be selected to improve the prognosis of non-surgical patients. Disclosure The authors declare that they have no conflicts of interest in association with the present study. IRB Information The present study was approved by Nippon Medical School Chiba Hokusoh Hospital (reference number: 841-3).